Global Phage Therapy Market Size by Type (Oral), by Application (Therapeutics) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261475
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Phage Therapy is the therapeutic use of lytic bacteriophages to treat pathogenic bacterial infections. Therapeutic phages have some advantages over antibiotics, and phages have been reported to be more effective than antibiotics in treating certain infections in humans and experimentally infected animals.

The Global Phage Therapy Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increase in the prevalence of bacterial infections and benefits over conventional antibiotics are going to propel the market. However, narrow spectrum activity of therapy may become the barrier to the market growth in the forecast period.

The global phage therapy market is primarily segmented based on different type, application and region. On the basis type, market is segmented into oral, external application and surgical treatment. On the basis of application, market is segmented into therapeutics, veterinary science, agriculture, food industry and aquaculture. On the basis of regions, market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

On the basis of type, the market is split into:
* Oral
* External Application
* Surgical Treatment

On the basis of application, the market is split into:
* Therapeutics
* Veterinary Science
* Agriculture
* Food Industry
* Aquaculture

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Adaptive Phage Therapeutics
* AmpliPhi Biosciences.
* C3J Therapeutics
* Enbiotix
* InnoPhage
* INtODEWorld
* Intralytix
* Locus Biosciences
* Phagomed.
* Phagelux

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type and application market size and their forecast from 2018-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions type and application with qualitative and quantitative information and facts

Target Audience:
* Phage Therapy Manufactures
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research follows by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Phage Therapy Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Phage Therapy Market - Porter\'s Five Forces Analysis
4.4. Global Phage Therapy Market - PESTEL Analysis

5. Global Phage Therapy Market, by Type
5.1. Global Phage Therapy Market, Size and Forecast, 2015-2026
5.2. Global Phage Therapy Market, by Oral, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Phage Therapy Market, by External Application, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Phage Therapy Market, by Surgical Treatment, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026

6. Global Phage Therapy Market, by Application
6.1. Global Phage Therapy Market, Size and Forecast, 2015-2026
6.2. Global Phage Therapy Market, by Therapeutics, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Phage Therapy Market, by Veterinary Science, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Phage Therapy Market, by Agriculture, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Phage Therapy Market, by Food Industry, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026
6.6. Global Phage Therapy Market, by Aquaculture, 2015-2026
6.6.1. Key driving factors, trends and opportunities
6.6.2. Market size and forecast, 2015-2026

7. Global Phage Therapy Market by Region
7.1. Phage Therapy Market Regional Analysis, 2015-2026
7.2. Global Phage Therapy Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Phage Therapy Market, 2015-2026
7.3.1. North America Phage Therapy Market Size and Forecast, 2015-2026
7.3.2. North America Phage Therapy Market by Country, 2015-2026
7.3.2.1. U.S. Phage Therapy Market, 2015-2026
7.3.2.2. Canada Phage Therapy Market, 2015-2026
7.4. Europe Phage Therapy Market, 2015-2026
7.4.1. Europe Phage Therapy Market Size and Forecast, 2015-2026
7.4.2. Europe Phage Therapy Market by Country, 2015-2026
7.4.2.1. Germany Phage Therapy Market, 2015-2026
7.4.2.2. France Phage Therapy Market, 2015-2026
7.4.2.3. Italy Phage Therapy Market, 2015-2026
7.4.2.4. UK Phage Therapy Market, 2015-2026
7.4.2.5. Spain Phage Therapy Market, 2015-2026
7.4.2.6. Rest of Europe Phage Therapy Market, 2015-2026
7.5. Asia Pacific Phage Therapy Market, 2015-2026
7.5.1. Asia Pacific Phage Therapy Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Phage Therapy Market by Country, 2015-2026
7.5.2.1. Japan Phage Therapy Market, 2015-2026
7.5.2.2. China Phage Therapy Market, 2015-2026
7.5.2.3. India Phage Therapy Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Phage Therapy Market, 2015-2026
7.6. South America Phage Therapy Market, 2015-2026
7.6.1. South America Phage Therapy Market Size and Forecast, 2015-2026
7.6.2. South America Phage Therapy Market by Country, 2015-2026
7.6.2.1. Mexico Phage Therapy Market, 2015-2026
7.6.2.2. Brazil Phage Therapy Market, 2015-2026
7.6.2.3. Rest of South America Phage Therapy Market, 2015-2026
7.7. Middle East & Africa Phage Therapy Market, 2015-2026
7.7.1. Middle East & Africa Phage Therapy Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Phage Therapy Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Phage Therapy Market, 2015-2026
7.7.2.2. South Africa Phage Therapy Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Phage Therapy Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Adaptive Phage Therapeutics
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. AmpliPhi Biosciences.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. C3J Therapeutics
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Enbiotix
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. InnoPhage
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. INtODEWorld
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Intralytix
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Locus Biosciences
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Phagomed.
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Phagelux
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type